Loading chart…
PRE-MARKET
Venus Remedies Limited engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally. The company is involved in the research and development of solutions focusing on antimicrobial resistance, oncology, skin and wound care, and pain management.
Venus Remedies Limited (VENUSREM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The VENUSREM share price is ₹1,510.90 (+4.21% today), with a market capitalisation of ₹20B and a price-to-earnings (P/E) ratio of 16.6. MarketRipple tracks the VENUSREM investment thesis, the ripple-chain impact of market events on Venus Remedies Limited, and the Healthcare sector outlook.
Open
₹1,480.00
High
₹1,520.00
Low
₹1,410.00
Prev. Close
₹1,449.90
52W High
₹2,044.30
52W Low
₹441.65
Day range
₹1,410.00–₹1,520.00
52-week range
₹441.65–₹2,044.30
Volume
23K
P/E
16.6
ROE
18.7%
D/E
0.02
Margin
14.5%
Venus Remedies Limited (NSE: VENUSREM) is currently trading at ₹1,510.90 (+4.21%).
Venus Remedies Limited's market capitalization is ₹20B.
Venus Remedies Limited's price-to-earnings (P/E) ratio is 16.6.
Venus Remedies Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).